Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
life sciences
4
×
national blog main
national top stories
new york blog main
boston blog main
deals
new york top stories
novartis
san diego blog main
san francisco blog main
wisconsin blog main
wisconsin top stories
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
cybersecurity
detroit blog main
detroit top stories
digital health
gene therapy
indiana blog main
indiana top stories
ipo
medical devices
meiragtx
national
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
startups
texas blog main
What
years
4
×
bigger
bio
deal
investors
ipo
new
roundup
acquisitions
age
allogene
announced
biggest
cancer
ceo
collabs
come
covid
crispr
daniel
deals
diversity
emerging
exits
founders
funding
gave
gene
gilead
gilead’s
health's
healthcare
help
hot
immunotherapy
initially
introduce
j
johnson
juno
Language
unset
Current search:
years
×
fda
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
